Novartis AG is 32.7x more valuable than Nuvalent, Inc. by market capitalization ($282.64 B vs $8.64 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | NUVL | NVS |
|---|---|---|
| Market cap | $8.64 B | $282.64 B |
| US-listed rank | #1031 | #47 |
| Net income (latest FY) | -$425.40M | - |
| SEC filings | 529 | 947 |
Novartis AG is 32.7x more valuable than Nuvalent, Inc. by market capitalization ($282.64 B vs $8.64 B).
Full pages: Nuvalent, Inc. and Novartis AG, or browse the full rankings.